{"id":6521,"date":"2022-03-11T18:32:24","date_gmt":"2022-03-11T10:32:24","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=6521"},"modified":"2023-01-10T14:24:10","modified_gmt":"2023-01-10T06:24:10","slug":"the-board-of-directors-approved-2021-consolidated-financial-statements","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-2021-consolidated-financial-statements\/","title":{"rendered":"The Board of Directors approved 2021 consolidated financial statements."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a05<\/td>\nDate of announcement<\/td>\n2022\/03\/11<\/td>\nTime of announcement<\/td>\n18:32:22<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved 2021 consolidated\r\nfinancial statements.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2022\/03\/11<\/td>\nTo which item it meets<\/td>\nparagraph 31<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of submission to the board of directors or \r\n  approval by the board of directors:2022\/03\/11\r\n2.Date of approval by the audit committee:2022\/03\/11\r\n3.Start and end dates of financial reports or annual\r\n  self-assessed financial information of the reporting\r\n  period (XXXX\/XX\/XX~XXXX\/XX\/XX):\r\n  2021\/01\/01~2021\/12\/31\r\n4.Operating revenue accumulated from 1\/1 to end of the\r\n  period (thousand NTD):6,573,152\r\n5.Gross profit (loss) from operations accumulated from\r\n  1\/1 to end of the period (thousand NTD):1,372,619\r\n6.Net operating income (loss) accumulated from 1\/1 to\r\n  end of the period (thousand NTD):595,026\r\n7.Profit (loss) before tax accumulated from 1\/1 to end\r\n  of the period (thousand NTD):873,736\r\n8.Profit (loss) accumulated from 1\/1 to end of the \r\n  period (thousand NTD):722,289\r\n9.Profit (loss) during the period attributable to owners\r\n  of parent accumulated from 1\/1 to end of the period \r\n  (thousand NTD):607,149\r\n10.Basic earnings (loss) per share accumulated from 1\/1\r\n   to end of the period (NTD):4.30\r\n11.Total assets end of the period (thousand NTD):\r\n   15,105,000\r\n12.Total liabilities end of the period (thousand NTD):\r\n   5,359,288\r\n13.Equity attributable to owners of parent end of the\r\n   period (thousand NTD):7,738,389\r\n14.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a05 Date of announcement 2022\/03\/11 Time of announcement 18:32:22 Subject The Board of Directors approved 2021 consolidated financial statements. Date of events 2022\/03\/11 To which item it meets paragraph 31 Statement 1.Date of submission to the board of directors or approval by the board of directors:2022\/03\/11 2.Date of approval by the audit committee:2022\/03\/11 …<\/p>\n
  The Board of Directors approved 2021 consolidated financial statements.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[102,72],"tags":[],"class_list":["post-6521","post","type-post","status-publish","format-standard","hentry","category-material-information","category-investors"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=6521"}],"version-history":[{"count":1,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6521\/revisions"}],"predecessor-version":[{"id":6522,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/6521\/revisions\/6522"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=6521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=6521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=6521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}